A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe2 +under physiologically relevant conditions

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 12, 2014, Pages 3299-3310

  Wong, Bruce X ^a   Ayton, Scott ^a   Lam, Linh Q ^a   Lei, Peng ^a   Adlard, Paul A ^a   Bush, Ashley I ^a   Duce, James A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Ceruloplasmin; Ferroxidase; Iron; Oxidation; Transferrin

Indexed keywords

CERULOPLASMIN; POLYANION; TRANSFERRIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; INTERMETHOD COMPARISON; IONIC STRENGTH; IRON METABOLISM; PH; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS;

EID: 84907148276     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.08.006     Document Type: Article

References (66)

1. K.J. Waldron, J.C. Rutherford, D. Ford, and N.J. Robinson Metalloproteins and metal sensing Nature 460 2009 823 830
2. D.A. Johnson, S. Osaki, and E. Frieden A micromethod for the determination of ferroxidase (ceruloplasmin) in human serums Clin. Chem. 13 1967 142 150
3. F. Haber, and J. Weiss The catalytic decomposition of hydrogen peroxide by iron salts Proc. R. Soc. Lond. A Math. Phys. Sci. 147 1934 332 351
4. H.J.H. Fenton LXXIII. - Oxidation of tartaric acid in presence of iron J. Chem. Soc. Trans. 65 1894 899 910
5. K.J. Davies Protein damage and degradation by oxygen radicals. I. General aspects J. Biol. Chem. 262 1987 9895 9901
6. T.F. Slater Free radical mechanisms in tissue injury L.E. Cañedo, L.E. Todd, L. Packer, J. Jaz, Cell Function and Disease 1988 Springer US 209 218
7. S.P. Wolff, A. Garner, and R.T. Dean Free radicals, lipids and protein degradation Trends Biochem. Sci. 11 1986 27 31
8. T.A. Rouault Iron metabolism in the CNS: implications for neurodegenerative diseases Nat. Rev. Neurosci. 14 2013 551 564
9. I. De Domenico, D.M. Ward, M.C. di Patti, S.Y. Jeong, S. David, G. Musci, and J. Kaplan Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin EMBO J. 26 2007 2823 2831
10. O. Han, and E.Y. Kim Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells J. Cell. Biochem. 101 2007 1000 1010
11. H. Chen, Z.K. Attieh, T. Su, B.A. Syed, H. Gao, R.M. Alaeddine, T.C. Fox, J. Usta, C.E. Naylor, R.W. Evans, A.T. McKie, G.J. Anderson, and C.D. Vulpe Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice Blood 103 2004 3933 3939
12. R.C. McCarthy, and D.J. Kosman Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux J. Biol. Chem. 288 2013 17932 17940
13. E. Nemeth, and T. Ganz Regulation of iron metabolism by hepcidin Annu. Rev. Nutr. 26 2006 323 342
14. S. Osaki, and D.A. Johnson Mobilization of liver iron by ferroxidase (ceruloplasmin) J. Biol. Chem. 244 1969 5757 5758
15. H.A. Ragan, S. Nacht, G.R. Lee, C.R. Bishop, and G.E. Cartwright Effect of ceruloplasmin on plasma iron in copper-deficient swine Am. J. Physiol. 217 1969 1320 1323
16. H.P. Roeser, G.R. Lee, S. Nacht, and G.E. Cartwright The role of ceruloplasmin in iron metabolism J. Clin. Invest. 49 1970 2408 2417
17. X. Xu, S. Pin, M. Gathinji, R. Fuchs, and Z.L. Harris Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis Ann. N. Y. Acad. Sci. 1012 2004 299 305
18. L.A. Meyer, A.P. Durley, J.R. Prohaska, and Z.L. Harris Copper transport and metabolism are normal in aceruloplasminemic mice J. Biol. Chem. 276 2001 36857 36861
19. D.J. Kosman Iron metabolism in aerobes: managing ferric iron hydrolysis and ferrous iron autoxidation Coord. Chem. Rev. 257 2013 210 217
20. L.W. Gray, T.Z. Kidane, A. Nguyen, S. Akagi, K. Petrasek, Y.L. Chu, A. Cabrera, K. Kantardjieff, A.Z. Mason, and M.C. Linder Copper proteins and ferroxidases in human plasma and that of wild-type and ceruloplasmin knockout mice Biochem. J. 419 2009 237 245
21. S. Haldar, J. Beveridge, J. Wong, A. Singh, D. Galimberti, B. Borroni, X. Zhu, J. Blevins, J. Greenlee, G. Perry, C.K. Mukhopadhyay, C. Schmotzer, and N. Singh A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD Antioxid. Redox Signal. 19 2013 1662 1675
22. K.J. Bharucha, J.K. Friedman, A.S. Vincent, and E.D. Ross Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease J. Neurol. 255 2008 1957 1962
23. L. Jin, J. Wang, H. Jin, G. Fei, Y. Zhang, W. Chen, L. Zhao, N. Zhao, X. Sun, M. Zeng, and C. Zhong Nigral iron deposition occurs across motor phenotypes of Parkinson's disease Eur. J. Neurol. 19 2012 969 976
24. L. Jin, J. Wang, L. Zhao, H. Jin, G. Fei, Y. Zhang, M. Zeng, and C. Zhong Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease Brain 134 2011 50 58
25. R. Martinez-Hernandez, S. Montes, J. Higuera-Calleja, P. Yescas, M.C. Boll, A. Diaz-Ruiz, and C. Rios Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study Neurochem. Res. 36 2011 2111 2115
26. G. Torsdottir, J. Kristinsson, J. Snaedal, and T. Johannesson Ceruloplasmin and iron proteins in the serum of patients with Alzheimer's disease Dement. Geriatr. Cogn. Disord. Extra 1 2011 366 371
27. G. Torsdottir, J. Kristinsson, S. Sveinbjornsdottir, J. Snaedal, and T. Johannesson Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease Pharmacol. Toxicol. 85 1999 239 243
28. M.C. Boll, M. Alcaraz-Zubeldia, S. Montes, and C. Rios Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases Neurochem. Res. 33 2008 1717 1723
29. M.C. Boll, J. Sotelo, E. Otero, M. Alcaraz-Zubeldia, and C. Rios Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease Neurosci. Lett. 265 1999 155 158
30. S. Olivieri, A. Conti, S. Iannaccone, C.V. Cannistraci, A. Campanella, M. Barbariga, F. Codazzi, I. Pelizzoni, G. Magnani, M. Pesca, D. Franciotta, S.F. Cappa, and M. Alessio Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention J. Neurosci. 31 2011 18568 18577
31. S. Ayton, P. Lei, J.A. Duce, B.X. Wong, A. Sedjahtera, P.A. Adlard, A.I. Bush, and D.I. Finkelstein Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease Ann. Neurol. 73 2013 554 559
32. R. Squitti, C. Salustri, M. Siotto, M. Ventriglia, F. Vernieri, D. Lupoi, E. Cassetta, and P.M. Rossini Ceruloplasmin/transferrin ratio changes in Alzheimer's disease Int. J. Alzheimers Dis. 2011 2010 231595
33. J.A. Duce, A. Tsatsanis, M.A. Cater, S.A. James, E. Robb, K. Wikhe, S.L. Leong, K. Perez, T. Johanssen, M.A. Greenough, H.H. Cho, D. Galatis, R.D. Moir, C.L. Masters, C. McLean, R.E. Tanzi, R. Cappai, K.J. Barnham, G.D. Ciccotosto, J.T. Rogers, and A.I. Bush Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 142 2010 857 867
34. G. Bartzokis, J.L. Cummings, C.H. Markham, P.Z. Marmarelis, L.J. Treciokas, T.A. Tishler, S.R. Marder, and J. Mintz MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects Magn. Reson. Imaging 17 1999 213 222
35. G. Bartzokis, D. Sultzer, J. Cummings, L.E. Holt, D.B. Hance, V.W. Henderson, and J. Mintz In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging Arch. Gen. Psychiatry 57 2000 47 53
36. G. Bartzokis, T.A. Tishler, I.S. Shin, P.H. Lu, and J.L. Cummings Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases Ann. N. Y. Acad. Sci. 1012 2004 224 236
37. E.P. Raven, P.H. Lu, T.A. Tishler, P. Heydari, and G. Bartzokis Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging J. Alzheimers Dis. 37 2013 127 136
38. S. Osaki, D.A. Johnson, and E. Frieden The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum J. Biol. Chem. 241 1966 2746 2751
39. G.R. Bakker, and R.F. Boyer Iron incorporation into apoferritin. The role of apoferritin as a ferroxidase J. Biol. Chem. 261 1986 13182 13185
40. T.A. Griffiths, A.G. Mauk, and R.T. MacGillivray Recombinant expression and functional characterization of human hephaestin: a multicopper oxidase with ferroxidase activity Biochemistry 44 2005 14725 14731
41. D. de Silva, S. Davis-Kaplan, J. Fergestad, and J. Kaplan Purification and characterization of Fet3 protein, a yeast homologue of ceruloplasmin J. Biol. Chem. 272 1997 14208 14213
42. O. Erel Automated measurement of serum ferroxidase activity Clin. Chem. 44 1998 2313 2319
43. E. Graf, J.R. Mahoney, R.G. Bryant, and J.W. Eaton Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site J. Biol. Chem. 259 1984 3620 3624
44. G. Minotti, and M. Ikeda-Saito Fe(II) oxidation and Fe(III) incorporation by the M(r) 66,000 microsomal iron protein that stimulates NADPH oxidation J. Biol. Chem. 267 1992 7611 7614
45. D.C. Harris, and P. Aisen Facilitation of Fe(II) autoxidation by Fe(3) complexing agents Biochim. Biophys. Acta 329 1973 156 158
46. R.M.C. Dawson Data for Biochemical Research 3rd ed. 1986 Clarendon Press Oxford
47. X. Yang, and N.D. Chasteen Ferroxidase activity of ferritin: effects of pH, buffer and Fe(II) and Fe(III) concentrations on Fe(II) autoxidation and ferroxidation Biochem. J. 338 Pt 3 1999 615 618
48. K.D. Welch, T.Z. Davis, and S.D. Aust Iron autoxidation and free radical generation: effects of buffers, ligands, and chelators Arch. Biochem. Biophys. 397 2002 360 369
49. K.H. Ebrahimi, P.L. Hagedoorn, and W.R. Hagen A synthetic peptide with the putative iron binding motif of amyloid precursor protein (APP) does not catalytically oxidize iron PLoS One 7 2012 e40287
50. G. Curzon The inhibition of caeruloplasmin by azide Biochem. J. 100 1966 295 302
51. R.W. Topham, and E. Frieden Identification and purification of a non-ceruloplasmin ferroxidase of human serum J. Biol. Chem. 245 1970 6698 6705
52. R.A. Copeland Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists 2005 Wiley-Interscience Hoboken, N.J.
53. E. Frieden, and P. Aisen Forms of iron transferrin Trends Biochem. Sci. 5 1980 (X)
54. P. Aisen, and I. Listowsky Iron transport and storage proteins Annu. Rev. Biochem. 49 1980 357 393
55. W.R. Harris Estimation of the ferrous-transferrin binding constants based on thermodynamic studies of nickel(II)-transferrin J. Inorg. Biochem. 27 1986 41 52
56. N. Kojima, and G.W. Bates The formation of Fe3+-transferrin-CO3(2-) via the binding and oxidation of Fe2 + J. Biol. Chem. 256 1981 12034 12039
57. R.A. Løvstad A comparative study of the two different activities of ceruloplasmin in human sera Eur. J. Biochem. 8 1969 303 306
58. P. Aisen, R. Aasa, B.G. Malmstrom, and T. Vanngard Bicarbonate and the binding of iron to transferrin J. Biol. Chem. 242 1967 2484 2490
59. V.L. Pecoraro, W.R. Harris, C.J. Carrano, and K.N. Raymond Siderophilin metal coordination. Difference ultraviolet spectroscopy of di-, tri-, and tetravalent metal ions with ethylenebis[(o-hydroxyphenyl)glycine] Biochemistry 20 1981 7033 7039
60. A.T. Tan, and R.C. Woodworth Ultraviolet difference spectral studies of conalbumin complexes with transition metal ions Biochemistry 8 1969 3711 3716
61. M.S. Shongwe, C.A. Smith, E.W. Ainscough, H.M. Baker, A.M. Brodie, and E.N. Baker Anion binding by human lactoferrin: results from crystallographic and physicochemical studies Biochemistry 31 1992 4451 4458
62. J. Dubach, B.J. Gaffney, K. More, G.R. Eaton, and S.S. Eaton Effect of the synergistic anion on electron paramagnetic resonance spectra of iron-transferrin anion complexes is consistent with bidentate binding of the anion Biophys. J. 59 1991 1091 1100
63. A.A. Foley, and G.W. Bates The influence of inorganic anions on the formation and stability of Fe3+-transferrin-anion complexes Biochim. Biophys. Acta 965 1988 154 162
64. T.B. Rogers, R.E. Feeney, and C.F. Meares Interaction of anions with iron-transferrin-chelate complexes J. Biol. Chem. 252 1977 8108 8112
65. M.R. Schlabach, and G.W. Bates The synergistic binding of anions and Fe3 + by transferrin. Implications for the interlocking sites hypothesis J. Biol. Chem. 250 1975 2182 2188
66. W.R. Farwell, and E.N. Taylor Serum anion gap, bicarbonate and biomarkers of inflammation in healthy individuals in a national survey CMAJ 182 2010 137 141